The legacy of Viagra and its originator, copyright, presents a complex picture for potential investors. While the revolutionary drug initially generated enormous profits , its exclusivity has expired , leading to rival options flooding the landscape . This reduction in pricing presents a significant obstacle for copyright and any company considerin